原创《依达拉奉治疗脑栓塞临床效果和不良反应分析》：本文关于依达拉奉论文范文,可以做为相关论文参考文献,与写作提纲思路参考。
[摘 要] 目的 研究依達拉奉治疗脑梗塞的临床疗效,并分析该药物应用过程中的不良反应.方法 方便选取该院2013年10月—2016年10月期间所收治的58例脑梗塞患者作为该次研究对象,按照治疗方法的不同将58例患者均分为两组,对照组和观察组,每组29例,予以对照组患者血栓通治疗,观察组行依达拉奉治疗,对 析两组患者的临床总有效率,治疗前、后神经功能缺损程度评分以及不良反应发生情况.结果 观察组的临床总有效率为93.10%,显著高于对照组（62.07%）；两组治疗前功能缺损程度评分差异无统计学意义,治疗后,观察组得到明显改善,且观察组的评分（10.46±4.15）分显著低于对照组（16.63±6.57）分,两组差异有统计学意义（P<0.05）；治疗期间,观察组有1例发生轻度发热,在未接受干预下,症状自行恢复,持续应用依达拉奉治疗,无不良反应.结论 给予脑梗塞患者依达拉奉治疗的临床效果明显,能够有效改善患者的临床症状,提高患者的生存质量,且不良反应少,安全性高,值得应用.
[关键词] 依达拉奉；脑栓塞；不良反应
[中图分类号] R743 [文献标识码] A [文章编号] 1674-0742（2017）07（a）-0141-03
Analysis of Clinical Effect and Adverse Reactions of Edaravone in Treatment of Cerebral Embolism
LIU Zhi-yang
Department of Neurology, Changshu Hospital Affiliated to Soochow University & First People"s Hospital of Changshou, Changshou, Jiangsu Province, 215500 China
[Abstract] Objective To research the clinical effect and adverse reactions of edaravone in treatment of cerebral embolism. Methods 58 cases of patients with cerebral embolism admitted and treated in our hospital from October 2013 to October 2016 were convenient selected and divided into two groups with 29 cases in each according to the treatment methods, the control group and the observation group were respectively treated with xueshuangtong and edaravone, and the total effective rate, nerve function defect degree and occurrence of adverse reactions before and after treatment were compared between the two groups. Results The total clinical effective rate in the observation group was obviously higher than that in the control group, （93.10% vs 62.07%）, and the difference in the nerve function defect degree between the two groups before treatment was not statistically significant, after treatment, the scores in the observation group were obviously improved and the score in the observation group was obviously lower than that in the control group[（10.46±4.15）points vs （16.63±6.57）points], and the difference was obvious with statistical significance（P<0.05）, during the treatment, there was 1 case with mild fever in the observation group and the patient recovered without intervention, and the continuous application of edaravone had no side effects. Conclusion The clinical effect of edaravone in treatment of cerebral embolism is obvious, which can effectively improve the clinical symptoms of patients and improve the survival quality with fewer adverse reactions and high safety, and it is worth promotion.
[Key words] Edaravone； Cerebral embolism； Adverse reactions
依达拉奉论文参考资料：
结论：依达拉奉治疗脑栓塞临床效果和不良反应分析为关于对写作依达拉奉论文范文与课题研究的大学硕士、相关本科毕业论文奥扎格雷论文开题报告范文和相关文献综述及职称论文参考文献资料下载有帮助。
